thrombin receptor peptide sfllrnp and Blood Clot

thrombin receptor peptide sfllrnp has been researched along with Blood Clot in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Baumbach, J; Bernlochner, I; Biasi, M; Bongiovanni, D; Buske, C; Condorelli, G; Klug, M; Laugwitz, KL; Lazareva, O; List, M; Lukas, M; Scheidt, MV; Spinner, CD; Ursu, S; Warth, S; Weidlich, S	1
Doerner, A; Friebel, J; Hassanein, A; Kränkel, N; Landmesser, U; Rauch, U; Steffens, D; Witkowski, M	1
Matsushita, T; Miyamoto, M; Ohno, M; Ohtake, A; Yamada, N	1
Grgurevich, S; Jacoski, MV; Jennings, LK; Li, JS; Michelson, AD; Tyagi, A	1
Cazenave, JP; Freund, M; Gachet, C; Leon, C; Ravanat, C	1

Trials

1 trial(s) available for thrombin receptor peptide sfllrnp and Blood Clot

Article	Year
Pharmacodynamic effects of clopidogrel in pediatric cardiac patients: a comparative study of platelet aggregation response. Platelets, 2012, Volume: 23, Issue:6 Topics: Adenosine Diphosphate; Adult; Arteries; Blood Platelets; Child, Preschool; Clopidogrel; Double-Blind Method; Female; Fetal Blood; Heart; Heart Diseases; Humans; Infant; Infant, Newborn; Male; Peptide Fragments; Placebos; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine	2012

Article

Year

Pharmacodynamic effects of clopidogrel in pediatric cardiac patients: a comparative study of platelet aggregation response.

Platelets, 2012, Volume: 23, Issue:6

Topics: Adenosine Diphosphate; Adult; Arteries; Blood Platelets; Child, Preschool; Clopidogrel; Double-Blind Method; Female; Fetal Blood; Heart; Heart Diseases; Humans; Infant; Infant, Newborn; Male; Peptide Fragments; Placebos; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine

2012

Other Studies

4 other study(ies) available for thrombin receptor peptide sfllrnp and Blood Clot

Article	Year
SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype. Cell death & disease, 2021, 01-05, Volume: 12, Issue:1 Topics: Adult; Blood Platelets; Case-Control Studies; COVID-19; Female; Germany; Humans; Leukocytes; Male; Middle Aged; P-Selectin; Peptide Fragments; Phenotype; Platelet Glycoprotein GPIIb-IIIa Complex; SARS-CoV-2; Thrombosis	2021
Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time? Thrombosis research, 2017, Volume: 149 Topics: Aged; Anticoagulants; Antithrombins; Blood Platelets; Dabigatran; Female; Humans; Male; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Thrombosis	2017
TRA-418, a thromboxane A2 receptor antagonist and prostacyclin receptor agonist, inhibits platelet-leukocyte interaction in human whole blood. Thrombosis and haemostasis, 2010, Volume: 104, Issue:4 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cell Communication; Cell Separation; Cells, Cultured; Epinephrine; Epoprostenol; Fatty Acids, Unsaturated; Flow Cytometry; Humans; Hydrazines; Leukocytes; Oxazines; Peptide Fragments; Platelet Activation; Receptors, Epoprostenol; Receptors, Thromboxane A2, Prostaglandin H2; Thrombosis	2010
Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity. Arteriosclerosis, thrombosis, and vascular biology, 2003, Oct-01, Volume: 23, Issue:10 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Platelets; Disease Models, Animal; Humans; Leukocytes; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; P-Selectin; Peptide Fragments; Phosphatidylserines; Plasma; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombin; Thrombosis	2003